EE146 Cost-effectiveness of Tepotinib for Patients With Previously Treated Advanced Non-Small Cell Lung Cancer Harboring Metex14 Skipping Alterations in Spain
Edurne Arriola(Institute of Cancer Research), Heidi De los Santos Real(Saint Louis University), Michael Brines(Northwell Health), H. Wheat, M. Morros, Edward W. Hook(University of Alabama at Birmingham), H. Vioix(Merck KGaA, Darmstadt (Germany)), Michael del Aguila, S. Fernandez Soberon(Saint Louis University), R. Batteson
Cited by 0
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
|Proceedings of the National Academy of Sciences|2004|654